You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.
NO
YES

HIGHLIGHTS

News Highlight Thumbnail -  Kedrion Biopharma strengthens its presence in Russia

CORPORATE

Kedrion Biopharma strengthens its presence in Russia

Memorandum of Understanding with Russian pharmaceutical companies for a joint plasma products manufacturing program

read more 

PLASMA & BIOTHERAPIES

FDA Acceptance of BLA Submission for Human Rabies Immunoglobulin

Announcement by Kedrion Biopharma and Kamada. Regulatory decision expected in August 2017

read more 

EVENTS

Kedrion took part in the 17th ESID Meeting with 44 international guests

The conference focused on new insights into PIDs’ diagnosis and therapies

read more 
  1. Kedrion - Feature thumbnail

    CORPORATE - 28-12-2016

    Kedrion Biopharma strengthens its presence in Russia

    Memorandum of Understanding with Russian pharmaceutical companies for a joint plasma products manufacturing program

    read more 
  2. PLASMA & BIOTHERAPIES - 08-11-2016

    FDA Acceptance of BLA Submission for Human Rabies Immunoglobulin

    Announcement by Kedrion Biopharma and Kamada. Regulatory decision expected in August 2017

    read more 
  3. FEATURED STORIES - 24-10-2016

    Hemophilia seen through children's eyes: Kedrion teams up with LA Kelley

    Three books of the series My First Factor Creation are now available for free download

    read more 
  4. EVENTS - 17-10-2016

    Kedrion took part in the 17th ESID Meeting with 44 international guests

    The conference focused on new insights into PIDs’ diagnosis and therapies

    read more 

Pages

For more information please contact: pressoffice@kedrion.com